You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations, except those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.
Click “OK” to confirm you are a Healthcare Professional.
The Medtronic Symplicity Spyral™ RDN System is shown to be safe and effective.
When overactive nerves cause higher sympathetic activity, it can lead to hypertension for many patients. The Medtronic Renal Denervation (RDN) procedure ablates these nerves to reduce sympathetic activity in the renal arteries and lower blood pressure.EXPLORE RDN
Review the European Society of Cardiology (ESC) guidelines for Medtronic renal denervation patients and other resources to determine which of your patients may benefit from RDN.VIEW PATIENT SELECTION CRITERIA
We can lower blood pressure with RDN.Dr. Michael Burnier, Nephrologist & Hypertension expert
All rights reserved. Medtronic, Medtronic logo and Further, Together are trademarks of Medtronic. All other brands are trademarks of a Medtronic company. For distribution only in markets where the Symplicity Spyral™ multi-electrode renal denervation catheter and Symplicity G3™ renal denervation RF generator have been approved. Not for distribution in the USA, Japan or France.